Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia.
Animals
Cathepsin C
/ genetics
Diabetic Nephropathies
/ metabolism
Disease Models, Animal
Female
Gene Knockdown Techniques
Glucose
/ metabolism
Humans
Hyperglycemia
/ metabolism
Insulin Resistance
Kidney
/ injuries
Membrane Proteins
Metabolic Syndrome
Obesity
Permeability
Podocytes
/ metabolism
RNA, Messenger
Rats
Rats, Zucker
Serum Albumin
/ metabolism
Transcriptome
Albumin permeability
Cathepsin C
Diabetic nephropathy
Hyperglycemia
Podocytes
Journal
Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
14
01
2020
revised:
08
04
2020
accepted:
09
04
2020
pubmed:
18
4
2020
medline:
27
10
2020
entrez:
18
4
2020
Statut:
ppublish
Résumé
A growing body of evidence suggests a role of proteolytic enzymes in the development of diabetic nephropathy. Cathepsin C (CatC) is a well-known regulator of inflammatory responses, but its involvement in podocyte and renal injury remains obscure. We used Zucker rats, a genetic model of metabolic syndrome and insulin resistance, to determine the presence, quantity, and activity of CatC in the urine. In addition to the animal study, we used two cellular models, immortalized human podocytes and primary rat podocytes, to determine mRNA and protein expression levels via RT-PCR, Western blot, and confocal microscopy, and to evaluate CatC activity. The role of CatC was analyzed in CatC-depleted podocytes using siRNA and glycolytic flux parameters were obtained from extracellular acidification rate (ECAR) measurements. In functional analyses, podocyte and glomerular permeability to albumin was determined. We found that podocytes express and secrete CatC, and a hyperglycemic environment increases CatC levels and activity. Both high glucose and non-specific activator of CatC phorbol 12-myristate 13-acetate (PMA) diminished nephrin, cofilin, and GLUT4 levels and induced cytoskeletal rearrangements, increasing albumin permeability in podocytes. These negative effects were completely reversed in CatC-depleted podocytes. Moreover, PMA, but not high glucose, increased glycolytic flux in podocytes. Finally, we demonstrated that CatC expression and activity are increased in the urine of diabetic Zucker rats. We propose a novel mechanism of podocyte injury in diabetes, providing deeper insight into the role of CatC in podocyte biology.
Identifiants
pubmed: 32302668
pii: S0167-4889(20)30081-1
doi: 10.1016/j.bbamcr.2020.118723
pii:
doi:
Substances chimiques
Membrane Proteins
0
RNA, Messenger
0
Serum Albumin
0
nephrin
0
Cathepsin C
EC 3.4.14.1
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
118723Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.